Furthermore, sleep deprivation and circadian disruption associated with OSA promote metabolic dysregulation, enhancing hepatic glucose production and gluconeogenesis, which exacerbate hyperglycemia and insulin resistance (58), along with SREBP1-mediated lipogenesis. This evidence concerns the gene SREBF1 and Insulin resistance.